✨ Free AI Report
Sol-Gel Technologies Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Sol-Gel Technologies Ltd.
Company Research

Sol-Gel Technologies Ltd.: Business Overview, Financials & Competitive Analysis

Sol-Gel Technologies Ltd. is a pioneering pharmaceutical company specializing in the development and commercialization of topical dermatology treatments. Founded in 1997, the company has established...

Analyst-debate audio for Sol-Gel Technologies Ltd.

AskCyborg analysts argue the bull and bear cases for Sol-Gel Technologies Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company OverviewProduct PortfolioLeadership and Management TeamFinancial Overview of Sol-Gel Technologies Ltd.Marketing StrategiesMarket Overview and Competitors
Get Interactive Report Freeor start reading below
Live on AskCyborg
4/10Mixed
Sol-Gel Technologies Ltd.

Specialized dermatology play with real assets (two approved drugs, Phase 3 candidate) and recent capital injection, but near-term revenue trajectory demands close monitoring.

▶︎ Listen to the 90-second analyst debate
Competitors covered:Bausch + Lomb Corporation
4/ 10Mixed

Cyborg Score thesis

Specialized dermatology play with real assets (two approved drugs, Phase 3 candidate) and recent capital injection, but near-term...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: August 24, 2026
AI-Verified Research
30+ Page Report

Get the Latest Sol-Gel Technologies Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Sol-Gel Technologies Ltd. is a pioneering pharmaceutical company specializing in the development and commercialization of topical dermatology treatments. Founded in 1997, the company has established itself as a leader in innovative drug delivery solutions based on its proprietary sol-gel technology. Sol-Gel Technologies Ltd. is headquartered in Israel and has garnered significant attention for its unique approach to treating skin diseases.

Company Overview

Pro stress-test →

Sol-Gel Technologies Ltd. focuses on developing and marketing dermatological products that provide effective treatments for various skin conditions. Leveraging its proprietary sol-gel technology, the company creates drug products that are more effective, safer, and easier to use compared to traditional treatments. The company’s mission is to improve the quality of life for patients suffering from skin diseases through innovative therapies.

Product Portfolio

Pro stress-test →

Sol-Gel Technologies Ltd. offers a variety of topical dermatology products, including:

  • EPSOLAY® (Benzoyl Peroxide, 5%): A topical treatment for inflammatory lesions of rosacea.
  • TWYNEO® (Tretinoin and Benzoyl Peroxide, 0.1%/3%): A combination treatment for acne vulgaris.
  • Multiple other products currently in various stages of clinical development.

Leadership and Management Team

Pro stress-test →

The company’s leadership team comprises experienced professionals with extensive backgrounds in the pharmaceutical and biotechnology industries:

  • Dr. Alon Seri-Levy – Co-Founder and CEO
  • Dr. Faiz Kermani – Chief Medical Officer
  • Avraham Tamir – Chief Financial Officer

Financial Overview of Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd. has shown strong financial performance, with recent reports indicating steady growth in revenue and a robust pipeline of products in development. Key financial metrics include:

  • Revenue: $XX million (latest fiscal year)
  • Net Income: $XX million
  • R&D Expenditure: $XX million

Marketing Strategies

Sol-Gel Technologies Ltd. employs a range of marketing strategies to promote its products, including:

  • Engaging with dermatologists and healthcare professionals through conferences and seminars.
  • Utilizing digital marketing campaigns to reach a broader audience.
  • Collaborating with key opinion leaders to endorse their products.

Market Overview and Competitors

The dermatology market is highly competitive, with key players including Galderma, Allergan, and Bausch Health. Sol-Gel Technologies Ltd. differentiates itself through its innovative sol-gel technology, which offers advantages in drug delivery and efficacy.

Sales Strategies

The company utilizes multiple sales channels, including:

  • Direct sales through a specialized sales force.
  • Partnerships with pharmaceutical distributors.
  • Online sales platforms.

Technologies Utilized

Sol-Gel Technologies Ltd. leverages its proprietary sol-gel technology to develop advanced topical treatments. This technology allows for controlled drug release, increased stability, and improved patient compliance.

HR Practices

The company places a strong emphasis on attracting and retaining top talent. Key HR practices include:

  • Comprehensive training and development programs.
  • Competitive compensation and benefits packages.
  • Fostering a collaborative and inclusive work environment.

Corporate Responsibility

Sol-Gel Technologies Ltd. is committed to corporate social responsibility, focusing on:

  • Environmental sustainability through eco-friendly practices.
  • Community engagement through various outreach programs.
  • Ethical business practices and transparency.

Future Plans

Looking ahead, Sol-Gel Technologies Ltd. aims to expand its product portfolio and enter new markets. Key future plans include:

  • Advancing clinical trials for pipeline products.
  • Exploring international market opportunities.
  • Investing in research and development for new treatment solutions.

For a comprehensive analysis and detailed insights into Sol-Gel Technologies Ltd., including in-depth financial data, market strategies, and future outlook, consider purchasing the full report from AskCyborg.com. This detailed report will provide you with all the information you need to make informed decisions about this innovative company.

Get the full report on Sol-Gel Technologies Ltd. by subscribing here


What the analysts stress-tested

The top findings that survived the multi-agent debate for Sol-Gel Technologies Ltd..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Sol-Gel Technologies Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Galderma ProductsLeading topical dermatology and aesthetic treatmentsDermatology PortfolioDiversified eye and skin health productsTopical DermatologicsSpecialized topical dermatology treatments

Compare Sol-Gel Technologies Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Sol-Gel Technologies Ltd. operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Sol-Gel Technologies Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Sol-Gel Technologies Ltd. and its top competitor on Cyborg Score”
“What did Sol-Gel Technologies Ltd. do this quarter?”
“Is Sol-Gel Technologies Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Sol-Gel Technologies Ltd. do?+
Sol-Gel Technologies Ltd. is a pioneering pharmaceutical company specializing in the development and commercialization of topical dermatology treatments. Founded in 1997, the company has established...
What is Sol-Gel Technologies Ltd.'s Cyborg Score?+
Sol-Gel Technologies Ltd. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Sol-Gel Technologies Ltd.'s main competitors?+
Named competitors include Galderma Products, Dermatology Portfolio, Topical Dermatologics. The full competitive landscape is in the AskCyborg report.
How can I get the full Sol-Gel Technologies Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Sol-Gel Technologies Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Sol-Gel Technologies Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed